|Articles|December 10, 2019
WCG Launches AIMS 4.1 Platform
Advertisement
WCG ACI Clinical has launched the latest iteration of its proprietary AIMS. AIMS 4.1 offers users of WCG's endpoint adjudication solutions an enhanced interface and workflow experience.
To learn more about AIMS 4.1, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
New ICON Survey Shows Sites Face Growing Delays and Communication Gaps During Study Startup
2
ACT Brief: Targeted Trial Growth, Site Startup Strains, and Leadership Shake-Up at FDA
3
How the FDA’s CNPV Program Is Reshaping Trial Operations and Accelerated Review Strategies
4
Voyxact Lands FDA Accelerated Approval Following Positive Results in Phase III VISIONARY Trial
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
